nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—ABCG2—Omeprazole—Barrett's esophagus	0.139	0.234	CbGbCtD
Imatinib—CYP2C19—Esomeprazole—Barrett's esophagus	0.106	0.177	CbGbCtD
Imatinib—CYP2C19—Omeprazole—Barrett's esophagus	0.0622	0.105	CbGbCtD
Imatinib—CYP1A2—Omeprazole—Barrett's esophagus	0.0574	0.0965	CbGbCtD
Imatinib—CYP2C9—Omeprazole—Barrett's esophagus	0.0517	0.087	CbGbCtD
Imatinib—CYP3A4—Esomeprazole—Barrett's esophagus	0.051	0.0858	CbGbCtD
Imatinib—ABCB1—Omeprazole—Barrett's esophagus	0.0502	0.0844	CbGbCtD
Imatinib—CYP2D6—Omeprazole—Barrett's esophagus	0.0473	0.0795	CbGbCtD
Imatinib—CYP3A4—Omeprazole—Barrett's esophagus	0.0301	0.0506	CbGbCtD
Imatinib—ORM1—bile—Barrett's esophagus	0.0119	0.164	CbGeAlD
Imatinib—CA6—exocrine gland—Barrett's esophagus	0.00739	0.102	CbGeAlD
Imatinib—DDR1—smooth muscle tissue—Barrett's esophagus	0.00498	0.0684	CbGeAlD
Imatinib—KIT—exocrine gland—Barrett's esophagus	0.00429	0.059	CbGeAlD
Imatinib—CA2—exocrine gland—Barrett's esophagus	0.00254	0.035	CbGeAlD
Imatinib—CA7—digestive system—Barrett's esophagus	0.00253	0.0347	CbGeAlD
Imatinib—PDGFRA—smooth muscle tissue—Barrett's esophagus	0.00225	0.0309	CbGeAlD
Imatinib—CA9—digestive system—Barrett's esophagus	0.00222	0.0305	CbGeAlD
Imatinib—CSF1R—smooth muscle tissue—Barrett's esophagus	0.00198	0.0272	CbGeAlD
Imatinib—KIT—epithelium—Barrett's esophagus	0.00187	0.0257	CbGeAlD
Imatinib—PDGFRB—epithelium—Barrett's esophagus	0.00182	0.0251	CbGeAlD
Imatinib—KIT—smooth muscle tissue—Barrett's esophagus	0.0018	0.0247	CbGeAlD
Imatinib—PDGFRA—digestive system—Barrett's esophagus	0.00178	0.0244	CbGeAlD
Imatinib—PDGFRB—smooth muscle tissue—Barrett's esophagus	0.00176	0.0241	CbGeAlD
Imatinib—SLC22A2—digestive system—Barrett's esophagus	0.00169	0.0232	CbGeAlD
Imatinib—CA12—digestive system—Barrett's esophagus	0.00164	0.0225	CbGeAlD
Imatinib—ABL1—smooth muscle tissue—Barrett's esophagus	0.00157	0.0215	CbGeAlD
Imatinib—CSF1R—digestive system—Barrett's esophagus	0.00156	0.0215	CbGeAlD
Imatinib—SLC47A1—digestive system—Barrett's esophagus	0.00143	0.0196	CbGeAlD
Imatinib—KIT—digestive system—Barrett's esophagus	0.00142	0.0195	CbGeAlD
Imatinib—PDGFRB—digestive system—Barrett's esophagus	0.00139	0.0191	CbGeAlD
Imatinib—CA1—digestive system—Barrett's esophagus	0.0013	0.0179	CbGeAlD
Imatinib—ABL1—digestive system—Barrett's esophagus	0.00124	0.017	CbGeAlD
Imatinib—CA2—epithelium—Barrett's esophagus	0.00111	0.0152	CbGeAlD
Imatinib—CA2—smooth muscle tissue—Barrett's esophagus	0.00107	0.0147	CbGeAlD
Imatinib—Haemolytic anaemia—Esomeprazole—Barrett's esophagus	0.00106	0.00399	CcSEcCtD
Imatinib—Haemolytic anaemia—Omeprazole—Barrett's esophagus	0.00106	0.00399	CcSEcCtD
Imatinib—Increased appetite—Esomeprazole—Barrett's esophagus	0.00102	0.00384	CcSEcCtD
Imatinib—Increased appetite—Omeprazole—Barrett's esophagus	0.00102	0.00384	CcSEcCtD
Imatinib—Purpura—Esomeprazole—Barrett's esophagus	0.000992	0.00374	CcSEcCtD
Imatinib—Purpura—Omeprazole—Barrett's esophagus	0.000992	0.00374	CcSEcCtD
Imatinib—Arthritis—Omeprazole—Barrett's esophagus	0.000984	0.00371	CcSEcCtD
Imatinib—Arthritis—Esomeprazole—Barrett's esophagus	0.000984	0.00371	CcSEcCtD
Imatinib—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00098	0.0037	CcSEcCtD
Imatinib—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00098	0.0037	CcSEcCtD
Imatinib—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00096	0.00362	CcSEcCtD
Imatinib—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00096	0.00362	CcSEcCtD
Imatinib—Pain in extremity—Omeprazole—Barrett's esophagus	0.000956	0.00361	CcSEcCtD
Imatinib—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.000956	0.00361	CcSEcCtD
Imatinib—Pain in extremity—Esomeprazole—Barrett's esophagus	0.000956	0.00361	CcSEcCtD
Imatinib—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.000956	0.00361	CcSEcCtD
Imatinib—Migraine—Omeprazole—Barrett's esophagus	0.000941	0.00355	CcSEcCtD
Imatinib—Migraine—Esomeprazole—Barrett's esophagus	0.000941	0.00355	CcSEcCtD
Imatinib—Face oedema—Esomeprazole—Barrett's esophagus	0.000923	0.00348	CcSEcCtD
Imatinib—Face oedema—Omeprazole—Barrett's esophagus	0.000923	0.00348	CcSEcCtD
Imatinib—CYP2C19—digestive system—Barrett's esophagus	0.000919	0.0126	CbGeAlD
Imatinib—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.000896	0.00338	CcSEcCtD
Imatinib—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.000896	0.00338	CcSEcCtD
Imatinib—Dry skin—Omeprazole—Barrett's esophagus	0.000877	0.00331	CcSEcCtD
Imatinib—Dry skin—Esomeprazole—Barrett's esophagus	0.000877	0.00331	CcSEcCtD
Imatinib—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.000874	0.00329	CcSEcCtD
Imatinib—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.000874	0.00329	CcSEcCtD
Imatinib—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00087	0.00328	CcSEcCtD
Imatinib—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00087	0.00328	CcSEcCtD
Imatinib—Breast disorder—Esomeprazole—Barrett's esophagus	0.000864	0.00326	CcSEcCtD
Imatinib—Breast disorder—Omeprazole—Barrett's esophagus	0.000864	0.00326	CcSEcCtD
Imatinib—Cramp muscle—Omeprazole—Barrett's esophagus	0.000861	0.00325	CcSEcCtD
Imatinib—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000861	0.00325	CcSEcCtD
Imatinib—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.000861	0.00325	CcSEcCtD
Imatinib—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.000861	0.00325	CcSEcCtD
Imatinib—Cramp muscle—Esomeprazole—Barrett's esophagus	0.000861	0.00325	CcSEcCtD
Imatinib—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.000861	0.00325	CcSEcCtD
Imatinib—PTGS1—epithelium—Barrett's esophagus	0.000855	0.0117	CbGeAlD
Imatinib—Gastritis—Esomeprazole—Barrett's esophagus	0.000846	0.00319	CcSEcCtD
Imatinib—Gastritis—Omeprazole—Barrett's esophagus	0.000846	0.00319	CcSEcCtD
Imatinib—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.000844	0.00318	CcSEcCtD
Imatinib—Muscular weakness—Omeprazole—Barrett's esophagus	0.000844	0.00318	CcSEcCtD
Imatinib—Muscular weakness—Esomeprazole—Barrett's esophagus	0.000844	0.00318	CcSEcCtD
Imatinib—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000844	0.00318	CcSEcCtD
Imatinib—CA2—digestive system—Barrett's esophagus	0.000842	0.0116	CbGeAlD
Imatinib—Abdominal distension—Omeprazole—Barrett's esophagus	0.000832	0.00314	CcSEcCtD
Imatinib—Abdominal distension—Esomeprazole—Barrett's esophagus	0.000832	0.00314	CcSEcCtD
Imatinib—Dysphagia—Esomeprazole—Barrett's esophagus	0.000827	0.00312	CcSEcCtD
Imatinib—Influenza—Omeprazole—Barrett's esophagus	0.000827	0.00312	CcSEcCtD
Imatinib—Influenza—Esomeprazole—Barrett's esophagus	0.000827	0.00312	CcSEcCtD
Imatinib—Dysphagia—Omeprazole—Barrett's esophagus	0.000827	0.00312	CcSEcCtD
Imatinib—PTGS1—smooth muscle tissue—Barrett's esophagus	0.000824	0.0113	CbGeAlD
Imatinib—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00081	0.00306	CcSEcCtD
Imatinib—Pancreatitis—Omeprazole—Barrett's esophagus	0.00081	0.00306	CcSEcCtD
Imatinib—Sweating increased—Omeprazole—Barrett's esophagus	0.000805	0.00304	CcSEcCtD
Imatinib—Sweating increased—Esomeprazole—Barrett's esophagus	0.000805	0.00304	CcSEcCtD
Imatinib—Angina pectoris—Esomeprazole—Barrett's esophagus	0.000805	0.00304	CcSEcCtD
Imatinib—Angina pectoris—Omeprazole—Barrett's esophagus	0.000805	0.00304	CcSEcCtD
Imatinib—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000785	0.00296	CcSEcCtD
Imatinib—Pancytopenia—Omeprazole—Barrett's esophagus	0.000785	0.00296	CcSEcCtD
Imatinib—Neutropenia—Esomeprazole—Barrett's esophagus	0.000773	0.00291	CcSEcCtD
Imatinib—Neutropenia—Omeprazole—Barrett's esophagus	0.000773	0.00291	CcSEcCtD
Imatinib—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000768	0.0029	CcSEcCtD
Imatinib—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000768	0.0029	CcSEcCtD
Imatinib—Pollakiuria—Esomeprazole—Barrett's esophagus	0.000764	0.00288	CcSEcCtD
Imatinib—Pollakiuria—Omeprazole—Barrett's esophagus	0.000764	0.00288	CcSEcCtD
Imatinib—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.000761	0.00287	CcSEcCtD
Imatinib—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.000761	0.00287	CcSEcCtD
Imatinib—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000755	0.00285	CcSEcCtD
Imatinib—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000755	0.00285	CcSEcCtD
Imatinib—Weight increased—Omeprazole—Barrett's esophagus	0.000752	0.00284	CcSEcCtD
Imatinib—Weight increased—Esomeprazole—Barrett's esophagus	0.000752	0.00284	CcSEcCtD
Imatinib—CYP1A2—digestive system—Barrett's esophagus	0.000751	0.0103	CbGeAlD
Imatinib—Weight decreased—Esomeprazole—Barrett's esophagus	0.000748	0.00282	CcSEcCtD
Imatinib—Weight decreased—Omeprazole—Barrett's esophagus	0.000748	0.00282	CcSEcCtD
Imatinib—Infestation—Esomeprazole—Barrett's esophagus	0.000737	0.00278	CcSEcCtD
Imatinib—Infestation NOS—Omeprazole—Barrett's esophagus	0.000737	0.00278	CcSEcCtD
Imatinib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.000737	0.00278	CcSEcCtD
Imatinib—Infestation—Omeprazole—Barrett's esophagus	0.000737	0.00278	CcSEcCtD
Imatinib—Depression—Esomeprazole—Barrett's esophagus	0.000735	0.00277	CcSEcCtD
Imatinib—Depression—Omeprazole—Barrett's esophagus	0.000735	0.00277	CcSEcCtD
Imatinib—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000731	0.00276	CcSEcCtD
Imatinib—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000731	0.00276	CcSEcCtD
Imatinib—Renal failure—Esomeprazole—Barrett's esophagus	0.000725	0.00273	CcSEcCtD
Imatinib—Renal failure—Omeprazole—Barrett's esophagus	0.000725	0.00273	CcSEcCtD
Imatinib—CYP3A5—digestive system—Barrett's esophagus	0.000724	0.00995	CbGeAlD
Imatinib—Stomatitis—Omeprazole—Barrett's esophagus	0.000718	0.00271	CcSEcCtD
Imatinib—Jaundice—Esomeprazole—Barrett's esophagus	0.000718	0.00271	CcSEcCtD
Imatinib—Stomatitis—Esomeprazole—Barrett's esophagus	0.000718	0.00271	CcSEcCtD
Imatinib—Jaundice—Omeprazole—Barrett's esophagus	0.000718	0.00271	CcSEcCtD
Imatinib—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000716	0.0027	CcSEcCtD
Imatinib—Urinary tract infection—Omeprazole—Barrett's esophagus	0.000716	0.0027	CcSEcCtD
Imatinib—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000716	0.0027	CcSEcCtD
Imatinib—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.000716	0.0027	CcSEcCtD
Imatinib—CYP2C9—digestive system—Barrett's esophagus	0.000713	0.00979	CbGeAlD
Imatinib—Haematuria—Omeprazole—Barrett's esophagus	0.000703	0.00265	CcSEcCtD
Imatinib—Haematuria—Esomeprazole—Barrett's esophagus	0.000703	0.00265	CcSEcCtD
Imatinib—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000697	0.00263	CcSEcCtD
Imatinib—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000697	0.00263	CcSEcCtD
Imatinib—Epistaxis—Esomeprazole—Barrett's esophagus	0.000695	0.00262	CcSEcCtD
Imatinib—Epistaxis—Omeprazole—Barrett's esophagus	0.000695	0.00262	CcSEcCtD
Imatinib—Sinusitis—Esomeprazole—Barrett's esophagus	0.000692	0.00261	CcSEcCtD
Imatinib—Sinusitis—Omeprazole—Barrett's esophagus	0.000692	0.00261	CcSEcCtD
Imatinib—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000688	0.00259	CcSEcCtD
Imatinib—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000688	0.00259	CcSEcCtD
Imatinib—Rhinitis—Esomeprazole—Barrett's esophagus	0.000663	0.0025	CcSEcCtD
Imatinib—Rhinitis—Omeprazole—Barrett's esophagus	0.000663	0.0025	CcSEcCtD
Imatinib—Hepatitis—Esomeprazole—Barrett's esophagus	0.000662	0.0025	CcSEcCtD
Imatinib—Hepatitis—Omeprazole—Barrett's esophagus	0.000662	0.0025	CcSEcCtD
Imatinib—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000658	0.00248	CcSEcCtD
Imatinib—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000658	0.00248	CcSEcCtD
Imatinib—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000657	0.00248	CcSEcCtD
Imatinib—Pharyngitis—Omeprazole—Barrett's esophagus	0.000657	0.00248	CcSEcCtD
Imatinib—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000653	0.00246	CcSEcCtD
Imatinib—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000653	0.00246	CcSEcCtD
Imatinib—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000652	0.00246	CcSEcCtD
Imatinib—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000652	0.00246	CcSEcCtD
Imatinib—PTGS1—digestive system—Barrett's esophagus	0.000651	0.00894	CbGeAlD
Imatinib—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00065	0.00245	CcSEcCtD
Imatinib—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00065	0.00245	CcSEcCtD
Imatinib—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000649	0.00245	CcSEcCtD
Imatinib—Urethral disorder—Omeprazole—Barrett's esophagus	0.000649	0.00245	CcSEcCtD
Imatinib—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000626	0.00236	CcSEcCtD
Imatinib—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000626	0.00236	CcSEcCtD
Imatinib—Eye disorder—Omeprazole—Barrett's esophagus	0.000618	0.00233	CcSEcCtD
Imatinib—Eye disorder—Esomeprazole—Barrett's esophagus	0.000618	0.00233	CcSEcCtD
Imatinib—Tinnitus—Esomeprazole—Barrett's esophagus	0.000617	0.00233	CcSEcCtD
Imatinib—Tinnitus—Omeprazole—Barrett's esophagus	0.000617	0.00233	CcSEcCtD
Imatinib—Flushing—Omeprazole—Barrett's esophagus	0.000614	0.00232	CcSEcCtD
Imatinib—Flushing—Esomeprazole—Barrett's esophagus	0.000614	0.00232	CcSEcCtD
Imatinib—Immune system disorder—Omeprazole—Barrett's esophagus	0.000598	0.00225	CcSEcCtD
Imatinib—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000598	0.00225	CcSEcCtD
Imatinib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000596	0.00225	CcSEcCtD
Imatinib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000596	0.00225	CcSEcCtD
Imatinib—Chills—Omeprazole—Barrett's esophagus	0.000594	0.00224	CcSEcCtD
Imatinib—Chills—Esomeprazole—Barrett's esophagus	0.000594	0.00224	CcSEcCtD
Imatinib—Alopecia—Omeprazole—Barrett's esophagus	0.000585	0.0022	CcSEcCtD
Imatinib—Alopecia—Esomeprazole—Barrett's esophagus	0.000585	0.0022	CcSEcCtD
Imatinib—Mental disorder—Esomeprazole—Barrett's esophagus	0.00058	0.00219	CcSEcCtD
Imatinib—Mental disorder—Omeprazole—Barrett's esophagus	0.00058	0.00219	CcSEcCtD
Imatinib—Malnutrition—Omeprazole—Barrett's esophagus	0.000576	0.00217	CcSEcCtD
Imatinib—Malnutrition—Esomeprazole—Barrett's esophagus	0.000576	0.00217	CcSEcCtD
Imatinib—Flatulence—Omeprazole—Barrett's esophagus	0.000568	0.00214	CcSEcCtD
Imatinib—Flatulence—Esomeprazole—Barrett's esophagus	0.000568	0.00214	CcSEcCtD
Imatinib—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000564	0.00213	CcSEcCtD
Imatinib—Dysgeusia—Omeprazole—Barrett's esophagus	0.000564	0.00213	CcSEcCtD
Imatinib—Back pain—Esomeprazole—Barrett's esophagus	0.000557	0.0021	CcSEcCtD
Imatinib—Back pain—Omeprazole—Barrett's esophagus	0.000557	0.0021	CcSEcCtD
Imatinib—Muscle spasms—Omeprazole—Barrett's esophagus	0.000554	0.00209	CcSEcCtD
Imatinib—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000554	0.00209	CcSEcCtD
Imatinib—CYP3A4—digestive system—Barrett's esophagus	0.000543	0.00747	CbGeAlD
Imatinib—Vision blurred—Esomeprazole—Barrett's esophagus	0.000543	0.00205	CcSEcCtD
Imatinib—Vision blurred—Omeprazole—Barrett's esophagus	0.000543	0.00205	CcSEcCtD
Imatinib—Tremor—Esomeprazole—Barrett's esophagus	0.00054	0.00203	CcSEcCtD
Imatinib—Tremor—Omeprazole—Barrett's esophagus	0.00054	0.00203	CcSEcCtD
Imatinib—CYP2D6—digestive system—Barrett's esophagus	0.000535	0.00735	CbGeAlD
Imatinib—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000534	0.00202	CcSEcCtD
Imatinib—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000534	0.00202	CcSEcCtD
Imatinib—Anaemia—Esomeprazole—Barrett's esophagus	0.000532	0.00201	CcSEcCtD
Imatinib—Anaemia—Omeprazole—Barrett's esophagus	0.000532	0.00201	CcSEcCtD
Imatinib—Angioedema—Esomeprazole—Barrett's esophagus	0.000526	0.00198	CcSEcCtD
Imatinib—Angioedema—Omeprazole—Barrett's esophagus	0.000526	0.00198	CcSEcCtD
Imatinib—Malaise—Omeprazole—Barrett's esophagus	0.000519	0.00196	CcSEcCtD
Imatinib—Malaise—Esomeprazole—Barrett's esophagus	0.000519	0.00196	CcSEcCtD
Imatinib—Vertigo—Omeprazole—Barrett's esophagus	0.000518	0.00195	CcSEcCtD
Imatinib—Vertigo—Esomeprazole—Barrett's esophagus	0.000518	0.00195	CcSEcCtD
Imatinib—Leukopenia—Esomeprazole—Barrett's esophagus	0.000516	0.00194	CcSEcCtD
Imatinib—Leukopenia—Omeprazole—Barrett's esophagus	0.000516	0.00194	CcSEcCtD
Imatinib—Palpitations—Esomeprazole—Barrett's esophagus	0.000509	0.00192	CcSEcCtD
Imatinib—Palpitations—Omeprazole—Barrett's esophagus	0.000509	0.00192	CcSEcCtD
Imatinib—ABCB1—epithelium—Barrett's esophagus	0.000506	0.00695	CbGeAlD
Imatinib—Cough—Esomeprazole—Barrett's esophagus	0.000503	0.0019	CcSEcCtD
Imatinib—Cough—Omeprazole—Barrett's esophagus	0.000503	0.0019	CcSEcCtD
Imatinib—Hypertension—Omeprazole—Barrett's esophagus	0.000497	0.00188	CcSEcCtD
Imatinib—Hypertension—Esomeprazole—Barrett's esophagus	0.000497	0.00188	CcSEcCtD
Imatinib—Arthralgia—Esomeprazole—Barrett's esophagus	0.00049	0.00185	CcSEcCtD
Imatinib—Myalgia—Esomeprazole—Barrett's esophagus	0.00049	0.00185	CcSEcCtD
Imatinib—Myalgia—Omeprazole—Barrett's esophagus	0.00049	0.00185	CcSEcCtD
Imatinib—Chest pain—Esomeprazole—Barrett's esophagus	0.00049	0.00185	CcSEcCtD
Imatinib—Arthralgia—Omeprazole—Barrett's esophagus	0.00049	0.00185	CcSEcCtD
Imatinib—Chest pain—Omeprazole—Barrett's esophagus	0.00049	0.00185	CcSEcCtD
Imatinib—Anxiety—Esomeprazole—Barrett's esophagus	0.000489	0.00184	CcSEcCtD
Imatinib—Anxiety—Omeprazole—Barrett's esophagus	0.000489	0.00184	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000487	0.00184	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000487	0.00184	CcSEcCtD
Imatinib—Discomfort—Esomeprazole—Barrett's esophagus	0.000485	0.00183	CcSEcCtD
Imatinib—Discomfort—Omeprazole—Barrett's esophagus	0.000485	0.00183	CcSEcCtD
Imatinib—Dry mouth—Omeprazole—Barrett's esophagus	0.00048	0.00181	CcSEcCtD
Imatinib—Dry mouth—Esomeprazole—Barrett's esophagus	0.00048	0.00181	CcSEcCtD
Imatinib—Confusional state—Omeprazole—Barrett's esophagus	0.000474	0.00179	CcSEcCtD
Imatinib—Confusional state—Esomeprazole—Barrett's esophagus	0.000474	0.00179	CcSEcCtD
Imatinib—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00047	0.00177	CcSEcCtD
Imatinib—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00047	0.00177	CcSEcCtD
Imatinib—Infection—Omeprazole—Barrett's esophagus	0.000467	0.00176	CcSEcCtD
Imatinib—Infection—Esomeprazole—Barrett's esophagus	0.000467	0.00176	CcSEcCtD
Imatinib—Shock—Esomeprazole—Barrett's esophagus	0.000462	0.00174	CcSEcCtD
Imatinib—Shock—Omeprazole—Barrett's esophagus	0.000462	0.00174	CcSEcCtD
Imatinib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000461	0.00174	CcSEcCtD
Imatinib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000461	0.00174	CcSEcCtD
Imatinib—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.00046	0.00174	CcSEcCtD
Imatinib—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.00046	0.00174	CcSEcCtD
Imatinib—Tachycardia—Esomeprazole—Barrett's esophagus	0.000459	0.00173	CcSEcCtD
Imatinib—Tachycardia—Omeprazole—Barrett's esophagus	0.000459	0.00173	CcSEcCtD
Imatinib—Skin disorder—Omeprazole—Barrett's esophagus	0.000457	0.00172	CcSEcCtD
Imatinib—Skin disorder—Esomeprazole—Barrett's esophagus	0.000457	0.00172	CcSEcCtD
Imatinib—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000454	0.00171	CcSEcCtD
Imatinib—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000454	0.00171	CcSEcCtD
Imatinib—Anorexia—Omeprazole—Barrett's esophagus	0.000448	0.00169	CcSEcCtD
Imatinib—Anorexia—Esomeprazole—Barrett's esophagus	0.000448	0.00169	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000428	0.00161	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000428	0.00161	CcSEcCtD
Imatinib—Insomnia—Esomeprazole—Barrett's esophagus	0.000425	0.0016	CcSEcCtD
Imatinib—Insomnia—Omeprazole—Barrett's esophagus	0.000425	0.0016	CcSEcCtD
Imatinib—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000422	0.00159	CcSEcCtD
Imatinib—Paraesthesia—Omeprazole—Barrett's esophagus	0.000422	0.00159	CcSEcCtD
Imatinib—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000419	0.00158	CcSEcCtD
Imatinib—Dyspnoea—Omeprazole—Barrett's esophagus	0.000419	0.00158	CcSEcCtD
Imatinib—Somnolence—Omeprazole—Barrett's esophagus	0.000418	0.00158	CcSEcCtD
Imatinib—Somnolence—Esomeprazole—Barrett's esophagus	0.000418	0.00158	CcSEcCtD
Imatinib—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000414	0.00156	CcSEcCtD
Imatinib—Dyspepsia—Omeprazole—Barrett's esophagus	0.000414	0.00156	CcSEcCtD
Imatinib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000409	0.00154	CcSEcCtD
Imatinib—Decreased appetite—Omeprazole—Barrett's esophagus	0.000409	0.00154	CcSEcCtD
Imatinib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000406	0.00153	CcSEcCtD
Imatinib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000406	0.00153	CcSEcCtD
Imatinib—Fatigue—Omeprazole—Barrett's esophagus	0.000405	0.00153	CcSEcCtD
Imatinib—Fatigue—Esomeprazole—Barrett's esophagus	0.000405	0.00153	CcSEcCtD
Imatinib—Constipation—Esomeprazole—Barrett's esophagus	0.000402	0.00152	CcSEcCtD
Imatinib—Pain—Omeprazole—Barrett's esophagus	0.000402	0.00152	CcSEcCtD
Imatinib—Pain—Esomeprazole—Barrett's esophagus	0.000402	0.00152	CcSEcCtD
Imatinib—Constipation—Omeprazole—Barrett's esophagus	0.000402	0.00152	CcSEcCtD
Imatinib—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000387	0.00146	CcSEcCtD
Imatinib—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000387	0.00146	CcSEcCtD
Imatinib—ABCB1—digestive system—Barrett's esophagus	0.000385	0.00528	CbGeAlD
Imatinib—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000384	0.00145	CcSEcCtD
Imatinib—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000384	0.00145	CcSEcCtD
Imatinib—Urticaria—Omeprazole—Barrett's esophagus	0.000373	0.00141	CcSEcCtD
Imatinib—Urticaria—Esomeprazole—Barrett's esophagus	0.000373	0.00141	CcSEcCtD
Imatinib—Abdominal pain—Omeprazole—Barrett's esophagus	0.000372	0.0014	CcSEcCtD
Imatinib—Body temperature increased—Omeprazole—Barrett's esophagus	0.000372	0.0014	CcSEcCtD
Imatinib—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000372	0.0014	CcSEcCtD
Imatinib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000372	0.0014	CcSEcCtD
Imatinib—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000346	0.00131	CcSEcCtD
Imatinib—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000346	0.00131	CcSEcCtD
Imatinib—Asthenia—Omeprazole—Barrett's esophagus	0.000337	0.00127	CcSEcCtD
Imatinib—Asthenia—Esomeprazole—Barrett's esophagus	0.000337	0.00127	CcSEcCtD
Imatinib—Pruritus—Omeprazole—Barrett's esophagus	0.000333	0.00125	CcSEcCtD
Imatinib—Pruritus—Esomeprazole—Barrett's esophagus	0.000333	0.00125	CcSEcCtD
Imatinib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000322	0.00121	CcSEcCtD
Imatinib—Diarrhoea—Omeprazole—Barrett's esophagus	0.000322	0.00121	CcSEcCtD
Imatinib—Dizziness—Omeprazole—Barrett's esophagus	0.000311	0.00117	CcSEcCtD
Imatinib—Dizziness—Esomeprazole—Barrett's esophagus	0.000311	0.00117	CcSEcCtD
Imatinib—Vomiting—Omeprazole—Barrett's esophagus	0.000299	0.00113	CcSEcCtD
Imatinib—Vomiting—Esomeprazole—Barrett's esophagus	0.000299	0.00113	CcSEcCtD
Imatinib—Rash—Esomeprazole—Barrett's esophagus	0.000296	0.00112	CcSEcCtD
Imatinib—Rash—Omeprazole—Barrett's esophagus	0.000296	0.00112	CcSEcCtD
Imatinib—Dermatitis—Esomeprazole—Barrett's esophagus	0.000296	0.00112	CcSEcCtD
Imatinib—Dermatitis—Omeprazole—Barrett's esophagus	0.000296	0.00112	CcSEcCtD
Imatinib—Headache—Esomeprazole—Barrett's esophagus	0.000294	0.00111	CcSEcCtD
Imatinib—Headache—Omeprazole—Barrett's esophagus	0.000294	0.00111	CcSEcCtD
Imatinib—Nausea—Esomeprazole—Barrett's esophagus	0.000279	0.00105	CcSEcCtD
Imatinib—Nausea—Omeprazole—Barrett's esophagus	0.000279	0.00105	CcSEcCtD
Imatinib—PTGS1—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.00011	0.00164	CbGpPWpGaD
Imatinib—LCK—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000109	0.00163	CbGpPWpGaD
Imatinib—ALB—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.000109	0.00163	CbGpPWpGaD
Imatinib—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	0.000108	0.00161	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000108	0.00161	CbGpPWpGaD
Imatinib—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000107	0.00159	CbGpPWpGaD
Imatinib—PTGS1—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000107	0.00159	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000107	0.00159	CbGpPWpGaD
Imatinib—KIT—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000103	0.00154	CbGpPWpGaD
Imatinib—CA7—Metabolism—SLC9A1—Barrett's esophagus	0.000103	0.00153	CbGpPWpGaD
Imatinib—ABL2—Developmental Biology—RELA—Barrett's esophagus	0.000102	0.00152	CbGpPWpGaD
Imatinib—ABL1—DNA Damage Response—TP53—Barrett's esophagus	0.000102	0.00152	CbGpPWpGaD
Imatinib—CA2—Metabolism—CYP26A1—Barrett's esophagus	0.000101	0.0015	CbGpPWpGaD
Imatinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000101	0.0015	CbGpPWpGaD
Imatinib—LCK—Signaling by Interleukins—RELA—Barrett's esophagus	0.0001	0.00149	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.0001	0.00149	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	9.96e-05	0.00148	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	9.88e-05	0.00147	CbGpPWpGaD
Imatinib—KIT—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	9.87e-05	0.00147	CbGpPWpGaD
Imatinib—ABL1—miRNA Regulation of DNA Damage Response—TP53—Barrett's esophagus	9.85e-05	0.00147	CbGpPWpGaD
Imatinib—PDGFRA—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	9.79e-05	0.00146	CbGpPWpGaD
Imatinib—CA9—Cellular responses to stress—CDKN2A—Barrett's esophagus	9.77e-05	0.00145	CbGpPWpGaD
Imatinib—LCK—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	9.75e-05	0.00145	CbGpPWpGaD
Imatinib—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	9.68e-05	0.00144	CbGpPWpGaD
Imatinib—CA1—Metabolism—CYP26A1—Barrett's esophagus	9.67e-05	0.00144	CbGpPWpGaD
Imatinib—CA12—Metabolism—SLC9A1—Barrett's esophagus	9.51e-05	0.00142	CbGpPWpGaD
Imatinib—CA9—Cellular responses to stress—RELA—Barrett's esophagus	9.4e-05	0.0014	CbGpPWpGaD
Imatinib—PDGFRA—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	9.34e-05	0.00139	CbGpPWpGaD
Imatinib—NTRK1—Signaling by NGF—RELA—Barrett's esophagus	9.18e-05	0.00137	CbGpPWpGaD
Imatinib—KIT—B Cell Activation—RELA—Barrett's esophagus	9.14e-05	0.00136	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	9.01e-05	0.00134	CbGpPWpGaD
Imatinib—ALB—Folate Metabolism—RELA—Barrett's esophagus	8.89e-05	0.00132	CbGpPWpGaD
Imatinib—CA9—Cellular responses to stress—CXCL8—Barrett's esophagus	8.86e-05	0.00132	CbGpPWpGaD
Imatinib—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	8.83e-05	0.00131	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	8.82e-05	0.00131	CbGpPWpGaD
Imatinib—PDGFRA—B Cell Activation—RELA—Barrett's esophagus	8.65e-05	0.00129	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	8.54e-05	0.00127	CbGpPWpGaD
Imatinib—CA9—Metabolism—CYP26A1—Barrett's esophagus	8.51e-05	0.00127	CbGpPWpGaD
Imatinib—PDGFRB—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	8.42e-05	0.00125	CbGpPWpGaD
Imatinib—ABL1—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	8.37e-05	0.00125	CbGpPWpGaD
Imatinib—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	8.37e-05	0.00125	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	8.3e-05	0.00124	CbGpPWpGaD
Imatinib—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	8.26e-05	0.00123	CbGpPWpGaD
Imatinib—NTRK1—MAPK Signaling Pathway—TP53—Barrett's esophagus	8.12e-05	0.00121	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	8.07e-05	0.0012	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	8.07e-05	0.0012	CbGpPWpGaD
Imatinib—ALB—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	8.03e-05	0.0012	CbGpPWpGaD
Imatinib—CA3—Metabolism—PPARG—Barrett's esophagus	8e-05	0.00119	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.86e-05	0.00117	CbGpPWpGaD
Imatinib—PDGFRB—B Cell Activation—RELA—Barrett's esophagus	7.79e-05	0.00116	CbGpPWpGaD
Imatinib—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	7.55e-05	0.00112	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	7.5e-05	0.00112	CbGpPWpGaD
Imatinib—ABL1—Cell Cycle—TP53—Barrett's esophagus	7.37e-05	0.0011	CbGpPWpGaD
Imatinib—NTRK1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	7.33e-05	0.00109	CbGpPWpGaD
Imatinib—CA2—Metabolism—SLC9A1—Barrett's esophagus	7.27e-05	0.00108	CbGpPWpGaD
Imatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	7.08e-05	0.00105	CbGpPWpGaD
Imatinib—ALB—Selenium Micronutrient Network—RELA—Barrett's esophagus	7.06e-05	0.00105	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.05e-05	0.00105	CbGpPWpGaD
Imatinib—NTRK1—Circadian rythm related genes—TP53—Barrett's esophagus	7.04e-05	0.00105	CbGpPWpGaD
Imatinib—ABL1—DNA Damage Response (only ATM dependent)—TP53—Barrett's esophagus	6.99e-05	0.00104	CbGpPWpGaD
Imatinib—CA1—Metabolism—SLC9A1—Barrett's esophagus	6.97e-05	0.00104	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—GAST—Barrett's esophagus	6.96e-05	0.00104	CbGpPWpGaD
Imatinib—ALB—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	6.86e-05	0.00102	CbGpPWpGaD
Imatinib—LCK—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	6.76e-05	0.00101	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—RELA—Barrett's esophagus	6.72e-05	0.001	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	6.66e-05	0.000991	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	6.62e-05	0.000985	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	6.55e-05	0.000974	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.43e-05	0.000957	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—RELA—Barrett's esophagus	6.37e-05	0.000947	CbGpPWpGaD
Imatinib—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	6.36e-05	0.000946	CbGpPWpGaD
Imatinib—CA3—Metabolism—PTGS2—Barrett's esophagus	6.29e-05	0.000936	CbGpPWpGaD
Imatinib—LCK—B Cell Activation—RELA—Barrett's esophagus	6.25e-05	0.00093	CbGpPWpGaD
Imatinib—CA9—Metabolism—SLC9A1—Barrett's esophagus	6.13e-05	0.000912	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	6.1e-05	0.000908	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—HGF—Barrett's esophagus	6.1e-05	0.000908	CbGpPWpGaD
Imatinib—ABL1—Factors involved in megakaryocyte development and platelet production—TP53—Barrett's esophagus	5.86e-05	0.000872	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	5.84e-05	0.000868	CbGpPWpGaD
Imatinib—ALB—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	5.83e-05	0.000867	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—RELA—Barrett's esophagus	5.73e-05	0.000853	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PTGES—Barrett's esophagus	5.67e-05	0.000844	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PTGES—Barrett's esophagus	5.62e-05	0.000837	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PTGES—Barrett's esophagus	5.61e-05	0.000835	CbGpPWpGaD
Imatinib—KIT—Disease—SLC9A1—Barrett's esophagus	5.58e-05	0.000831	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	5.5e-05	0.000818	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PTGES—Barrett's esophagus	5.45e-05	0.000811	CbGpPWpGaD
Imatinib—CA9—Cellular responses to stress—TP53—Barrett's esophagus	5.44e-05	0.000809	CbGpPWpGaD
Imatinib—ABL1—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	5.39e-05	0.000802	CbGpPWpGaD
Imatinib—PDGFRA—Disease—SLC9A1—Barrett's esophagus	5.28e-05	0.000786	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PTGES—Barrett's esophagus	5.23e-05	0.000779	CbGpPWpGaD
Imatinib—CA14—Metabolism—PPARG—Barrett's esophagus	5.15e-05	0.000767	CbGpPWpGaD
Imatinib—ALB—Folate Metabolism—TP53—Barrett's esophagus	5.14e-05	0.000765	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—GAST—Barrett's esophagus	5.1e-05	0.000759	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	5.08e-05	0.000757	CbGpPWpGaD
Imatinib—PDGFRB—MAPK Signaling Pathway—TP53—Barrett's esophagus	5.08e-05	0.000755	CbGpPWpGaD
Imatinib—LCK—Hemostasis—HGF—Barrett's esophagus	5.03e-05	0.000748	CbGpPWpGaD
Imatinib—CA6—Metabolism—PPARG—Barrett's esophagus	5.02e-05	0.000747	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—GAST—Barrett's esophagus	4.83e-05	0.000718	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—SST—Barrett's esophagus	4.77e-05	0.00071	CbGpPWpGaD
Imatinib—PDGFRB—Disease—SLC9A1—Barrett's esophagus	4.76e-05	0.000708	CbGpPWpGaD
Imatinib—CA7—Metabolism—PPARG—Barrett's esophagus	4.69e-05	0.000698	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	4.68e-05	0.000697	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—RELA—Barrett's esophagus	4.6e-05	0.000685	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	4.46e-05	0.000664	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—PPARG—Barrett's esophagus	4.46e-05	0.000663	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—GAST—Barrett's esophagus	4.35e-05	0.000647	CbGpPWpGaD
Imatinib—CA12—Metabolism—PPARG—Barrett's esophagus	4.34e-05	0.000646	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	4.3e-05	0.00064	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	4.26e-05	0.000634	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CYP26A1—Barrett's esophagus	4.26e-05	0.000634	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CYP26A1—Barrett's esophagus	4.25e-05	0.000633	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CYP26A1—Barrett's esophagus	4.13e-05	0.000615	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.08e-05	0.000608	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PTGES—Barrett's esophagus	4.06e-05	0.000605	CbGpPWpGaD
Imatinib—CA14—Metabolism—PTGS2—Barrett's esophagus	4.05e-05	0.000603	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CYP26A1—Barrett's esophagus	3.97e-05	0.00059	CbGpPWpGaD
Imatinib—CA6—Metabolism—PTGS2—Barrett's esophagus	3.95e-05	0.000588	CbGpPWpGaD
Imatinib—KIT—Immune System—HGF—Barrett's esophagus	3.85e-05	0.000573	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—RELA—Barrett's esophagus	3.84e-05	0.000571	CbGpPWpGaD
Imatinib—LCK—Disease—SLC9A1—Barrett's esophagus	3.82e-05	0.000568	CbGpPWpGaD
Imatinib—CA7—Metabolism—PTGS2—Barrett's esophagus	3.69e-05	0.000549	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—RELA—Barrett's esophagus	3.68e-05	0.000548	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—HGF—Barrett's esophagus	3.64e-05	0.000542	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—RELA—Barrett's esophagus	3.63e-05	0.00054	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—RELA—Barrett's esophagus	3.61e-05	0.000537	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.58e-05	0.000532	CbGpPWpGaD
Imatinib—ALB—Metabolism—PTGES—Barrett's esophagus	3.5e-05	0.000521	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—SST—Barrett's esophagus	3.49e-05	0.00052	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—GAST—Barrett's esophagus	3.49e-05	0.000519	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—RELA—Barrett's esophagus	3.49e-05	0.000519	CbGpPWpGaD
Imatinib—CA12—Metabolism—PTGS2—Barrett's esophagus	3.42e-05	0.000508	CbGpPWpGaD
Imatinib—CA2—Metabolism—PPARG—Barrett's esophagus	3.32e-05	0.000494	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—SST—Barrett's esophagus	3.31e-05	0.000492	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—HGF—Barrett's esophagus	3.28e-05	0.000489	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—RELA—Barrett's esophagus	3.27e-05	0.000487	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	3.23e-05	0.000481	CbGpPWpGaD
Imatinib—ABL1—Immune System—HGF—Barrett's esophagus	3.2e-05	0.000476	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—RELA—Barrett's esophagus	3.19e-05	0.000474	CbGpPWpGaD
Imatinib—CA1—Metabolism—PPARG—Barrett's esophagus	3.18e-05	0.000474	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PTGES—Barrett's esophagus	3.14e-05	0.000468	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—RELA—Barrett's esophagus	3.14e-05	0.000467	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	3.1e-05	0.000461	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	3.08e-05	0.000458	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—SLC9A1—Barrett's esophagus	3.07e-05	0.000457	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PTGES—Barrett's esophagus	3.07e-05	0.000456	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—SLC9A1—Barrett's esophagus	3.07e-05	0.000456	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.05e-05	0.000454	CbGpPWpGaD
Imatinib—ALB—Hemostasis—HGF—Barrett's esophagus	3e-05	0.000447	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—SST—Barrett's esophagus	2.98e-05	0.000443	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—SLC9A1—Barrett's esophagus	2.98e-05	0.000443	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PTGES—Barrett's esophagus	2.89e-05	0.00043	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PTGES—Barrett's esophagus	2.86e-05	0.000426	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—SLC9A1—Barrett's esophagus	2.86e-05	0.000425	CbGpPWpGaD
Imatinib—CA9—Metabolism—PPARG—Barrett's esophagus	2.8e-05	0.000417	CbGpPWpGaD
Imatinib—ALB—Metabolism—CYP26A1—Barrett's esophagus	2.65e-05	0.000395	CbGpPWpGaD
Imatinib—KIT—Disease—APC—Barrett's esophagus	2.64e-05	0.000393	CbGpPWpGaD
Imatinib—LCK—Immune System—HGF—Barrett's esophagus	2.63e-05	0.000392	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—RELA—Barrett's esophagus	2.62e-05	0.000391	CbGpPWpGaD
Imatinib—CA2—Metabolism—PTGS2—Barrett's esophagus	2.61e-05	0.000389	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—APC—Barrett's esophagus	2.52e-05	0.000375	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—RELA—Barrett's esophagus	2.52e-05	0.000375	CbGpPWpGaD
Imatinib—CA1—Metabolism—PTGS2—Barrett's esophagus	2.5e-05	0.000373	CbGpPWpGaD
Imatinib—PDGFRA—Disease—APC—Barrett's esophagus	2.5e-05	0.000372	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PTGES—Barrett's esophagus	2.45e-05	0.000364	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.4e-05	0.000357	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—SST—Barrett's esophagus	2.39e-05	0.000356	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	2.38e-05	0.000354	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	2.32e-05	0.000346	CbGpPWpGaD
Imatinib—PDGFRB—Disease—APC—Barrett's esophagus	2.25e-05	0.000335	CbGpPWpGaD
Imatinib—KIT—Immune System—RELA—Barrett's esophagus	2.23e-05	0.000332	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	2.22e-05	0.00033	CbGpPWpGaD
Imatinib—CA9—Metabolism—PTGS2—Barrett's esophagus	2.2e-05	0.000328	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.19e-05	0.000326	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.17e-05	0.000323	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—RELA—Barrett's esophagus	2.11e-05	0.000315	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—TP53—Barrett's esophagus	2.05e-05	0.000305	CbGpPWpGaD
Imatinib—KIT—Disease—PTGS2—Barrett's esophagus	2e-05	0.000298	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—RELA—Barrett's esophagus	1.97e-05	0.000293	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.96e-05	0.000292	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	1.93e-05	0.000287	CbGpPWpGaD
Imatinib—ALB—Metabolism—SLC9A1—Barrett's esophagus	1.91e-05	0.000285	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—RELA—Barrett's esophagus	1.91e-05	0.000284	CbGpPWpGaD
Imatinib—PDGFRA—Disease—PTGS2—Barrett's esophagus	1.9e-05	0.000282	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	1.89e-05	0.000281	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CXCL8—Barrett's esophagus	1.86e-05	0.000276	CbGpPWpGaD
Imatinib—ABL1—Immune System—RELA—Barrett's esophagus	1.86e-05	0.000276	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	1.86e-05	0.000276	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—APC—Barrett's esophagus	1.85e-05	0.000275	CbGpPWpGaD
Imatinib—LCK—Disease—APC—Barrett's esophagus	1.81e-05	0.000269	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.76e-05	0.000262	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—APC—Barrett's esophagus	1.75e-05	0.00026	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	1.72e-05	0.000255	CbGpPWpGaD
Imatinib—PDGFRB—Disease—PTGS2—Barrett's esophagus	1.71e-05	0.000254	CbGpPWpGaD
Imatinib—LCK—Hemostasis—TP53—Barrett's esophagus	1.69e-05	0.000251	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	1.68e-05	0.000249	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.6e-05	0.000239	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.58e-05	0.000235	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—APC—Barrett's esophagus	1.58e-05	0.000235	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.57e-05	0.000233	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.54e-05	0.000229	CbGpPWpGaD
Imatinib—LCK—Immune System—RELA—Barrett's esophagus	1.53e-05	0.000228	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—RELA—Barrett's esophagus	1.44e-05	0.000215	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.43e-05	0.000213	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PPARG—Barrett's esophagus	1.41e-05	0.000211	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PPARG—Barrett's esophagus	1.4e-05	0.000209	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PPARG—Barrett's esophagus	1.4e-05	0.000208	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.38e-05	0.000206	CbGpPWpGaD
Imatinib—LCK—Disease—PTGS2—Barrett's esophagus	1.37e-05	0.000204	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.37e-05	0.000204	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—RELA—Barrett's esophagus	1.37e-05	0.000203	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CXCL8—Barrett's esophagus	1.36e-05	0.000203	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PPARG—Barrett's esophagus	1.36e-05	0.000202	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	1.34e-05	0.000199	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PPARG—Barrett's esophagus	1.3e-05	0.000194	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CXCL8—Barrett's esophagus	1.29e-05	0.000192	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—APC—Barrett's esophagus	1.26e-05	0.000188	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.26e-05	0.000188	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—RELA—Barrett's esophagus	1.23e-05	0.000183	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CXCL8—Barrett's esophagus	1.16e-05	0.000173	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TP53—Barrett's esophagus	1.14e-05	0.00017	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PTGS2—Barrett's esophagus	1.11e-05	0.000166	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PTGS2—Barrett's esophagus	1.1e-05	0.000164	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PTGS2—Barrett's esophagus	1.1e-05	0.000164	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.08e-05	0.00016	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PTGS2—Barrett's esophagus	1.07e-05	0.000159	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.03e-05	0.000154	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PTGS2—Barrett's esophagus	1.03e-05	0.000153	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PPARG—Barrett's esophagus	1.01e-05	0.000151	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TP53—Barrett's esophagus	1.01e-05	0.00015	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—RELA—Barrett's esophagus	9.88e-06	0.000147	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CXCL8—Barrett's esophagus	9.31e-06	0.000139	CbGpPWpGaD
Imatinib—ALB—Metabolism—PPARG—Barrett's esophagus	8.73e-06	0.00013	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TP53—Barrett's esophagus	8.35e-06	0.000124	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	7.97e-06	0.000119	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TP53—Barrett's esophagus	7.91e-06	0.000118	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PPARG—Barrett's esophagus	7.84e-06	0.000117	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PPARG—Barrett's esophagus	7.65e-06	0.000114	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PPARG—Barrett's esophagus	7.21e-06	0.000107	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PPARG—Barrett's esophagus	7.14e-06	0.000106	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TP53—Barrett's esophagus	7.12e-06	0.000106	CbGpPWpGaD
Imatinib—ALB—Metabolism—PTGS2—Barrett's esophagus	6.87e-06	0.000102	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	6.16e-06	9.17e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PPARG—Barrett's esophagus	6.1e-06	9.09e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PTGS2—Barrett's esophagus	6.02e-06	8.95e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TP53—Barrett's esophagus	5.72e-06	8.51e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	5.67e-06	8.44e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	5.62e-06	8.36e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	4.8e-06	7.15e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	4.71e-06	7.01e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	3.71e-06	5.52e-05	CbGpPWpGaD
